Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohort.
Juvenile scleroderma
diffuse cutaneous subset
juvenile systemic sclerosis
limited cutaneous subset
organ involvement
patient-related outcomes
Journal
Journal of scleroderma and related disorders
ISSN: 2397-1991
Titre abrégé: J Scleroderma Relat Disord
Pays: England
ID NLM: 101685427
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
16
03
2018
accepted:
01
07
2018
entrez:
6
4
2022
pubmed:
1
2
2019
medline:
1
2
2019
Statut:
ppublish
Résumé
Juvenile systemic sclerosis is an orphan disease. Currently, the majority of juvenile systemic sclerosis cohort studies are retrospective in design without standardized assessment. This study was conducted prospectively to investigate the difference in manifestations of limited cutaneous juvenile systemic sclerosis and diffuse cutaneous juvenile systemic sclerosis subtypes. An additional aim was to compare these data to other juvenile systemic sclerosis cohorts and a large adult systemic sclerosis cohort. Patients fulfilling the Paediatric Rheumatology European Society juvenile systemic sclerosis classification criteria were included. Clinical characteristics and patient-related outcomes were assessed. In all, 88 patients with a mean disease duration of 3.5 years were enrolled, 72.5% with diffuse cutaneous juvenile systemic sclerosis with a mean modified Rodnan Skin score of 18 and 27.5% with limited cutaneous juvenile systemic sclerosis with mean modified Rodnan Skin score of 9. The mean age at the onset of Raynaud's and first non-Raynaud's symptoms was similar in both groups, approximately 9 and 10.5 years. Active digital tip ulcerations were present in 29% diffuse cutaneous juvenile systemic sclerosis and none in the limited cutaneous juvenile systemic sclerosis subjects (p = 0.005). Of those with cardiopulmonary testing, 3% of diffuse cutaneous juvenile systemic sclerosis and 23% of limited cutaneous juvenile systemic sclerosis group had cardiac involvement (p = 0.015), and 41% diffuse cutaneous juvenile systemic sclerosis and 22% of the limited cutaneous juvenile systemic sclerosis group had pulmonary involvement (p = 0.009). Physician global disease damage assessment was higher in the diffuse cutaneous juvenile systemic sclerosis group compared to the limited cutaneous juvenile systemic sclerosis group: 35 and 15 (p = 0.021). The majority of this international juvenile systemic sclerosis cohort had diffuse cutaneous juvenile systemic sclerosis (72.5%) with more frequent vascular and pulmonary involvement compared to the limited cutaneous group, who had increased cardiac involvement. Our cohort reflects prior findings of published juvenile systemic sclerosis cohorts and emphasizes a difference in the presentation compared to adult-onset systemic sclerosis.
Identifiants
pubmed: 35382144
doi: 10.1177/2397198318790494
pii: 10.1177_2397198318790494
pmc: PMC8922583
doi:
Types de publication
Journal Article
Langues
eng
Pagination
49-61Informations de copyright
© The Author(s) 2018.
Déclaration de conflit d'intérêts
Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
Références
J Scleroderma Relat Disord. 2016 May-Aug;1(2):177-240
pubmed: 29242839
J Rheumatol. 1988 Feb;15(2):202-5
pubmed: 3361530
J Dermatol. 2007 Sep;34(9):658-61
pubmed: 17727371
Arthritis Care Res (Hoboken). 2014 Mar;66(3):404-10
pubmed: 23983017
Clin Rheumatol. 2007 Aug;26(8):1259-62
pubmed: 17180299
Rheumatology (Oxford). 2000 May;39(5):556-9
pubmed: 10852989
Ann Rheum Dis. 2016 Sep;75(9):1736-40
pubmed: 27353738
J Rheumatol. 2014 Jun;41(6):1040-8
pubmed: 24833760
J Rheumatol. 2006 May;33(5):1004-13
pubmed: 16583463
Arthritis Rheum. 2006 Dec;54(12):3971-8
pubmed: 17133611
Arthritis Care Res (Hoboken). 2010 Feb;62(2):213-8
pubmed: 20191520
Ann Rheum Dis. 2012 Aug;71(8):1355-60
pubmed: 22615460
Rheumatology (Oxford). 2011 Jan;50(1):60-8
pubmed: 21148153
Ann Rheum Dis. 2016 Jan;75(1):163-9
pubmed: 25342760
Pediatr Rheumatol Online J. 2007 May 01;5:6
pubmed: 17550632
Rheumatology (Oxford). 2009 Jun;48 Suppl 3:iii32-5
pubmed: 19487221
Lupus. 2018 Mar;27(3):494-500
pubmed: 29251171
Arthritis Care Res (Hoboken). 2012 Sep;64(9):1405-14
pubmed: 22556030
Arthritis Rheum. 2007 Mar 15;57(2):203-12
pubmed: 17330294
Pediatr Rheumatol Online J. 2017 Apr 17;15(1):30
pubmed: 28416023
J Rheumatol. 2002 Aug;29(8):1767-73
pubmed: 12180742
J Scleroderma Relat Disord. 2017 Jan-Apr;2(1):11-18
pubmed: 28516167
Ann Rheum Dis. 2011 Oct;70(10):1788-92
pubmed: 21784727
Rheumatology (Oxford). 2016 May;55(5):883-90
pubmed: 26843483